FDA Investigator Conner N Mann
Conner N Mann has inspections in 2 countries as of 22 Sep 2023. Conner N Mann has collaborated with a combined 1119 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
7
Last Inspection Date:
22 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
India
Co-Investigator(s):
Ademola O Daramola,
Adree N Anderson,
Ashley A Mutawakkil,
Barbara Janine Breithaupt,
Bichsa T Tran,
Brent T Hall,
Brian D Nicholson,
Brittny C Cargo,
Carl A Huffman, III,
CDR Ileana Barreto Pettit,
Charanjeet Jassal,
Christopher S Keating,
Conner Mann,
Cynthia M Goudeau,
Danial S Hutchison,
Dawn E Barkans,
Dina K West,
Dina Kloost,
Dipesh K Shah,
Eric M Mueller, PharmD,
Erika V Butler,
Farhana Khan,
Gina C Chen,
Gretchen Lf Trendel,
Gwyn G Dickinson,
James C Maclaughlin,
James I Giefer,
James K Rice,
Jeffery L Sumter,
Jeffrey B Moody,
Jennifer L Huntington,
Jimmie L Weigand,
John A Iwen,
Kham Phommachanh,
Laura S Huffman,
Lisa L Gilliam,
Mark W Rivero,
Matthew B Casale,
Michael C Zubelewicz,
Michele L Obert,
Michele Perry Williams,
Miguel A Martinez,
Muralidhara B Gavini, PhD,
Nadeem I Chaudhry,
Nicole M Bell,
Philip J Boston,
Pratik S Upadhyay, DDC,
Rita K Kabaso,
Robert J Ham,
Shafiq S Ahadi,
Shanna R Haden,
Shirley J Berryman,
Steven D Kehoe,
Susanna E Ford, Analyst,
Tara L Greene,
Torrey M Ward,
Victoria A Wagoner,
Warren J Lopicka,
Wayne D Mcgrath,
William C Corley,
Zachary A Bogorad,
Zedong Dong
Conner N Mann's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2023 | FDA 483 | Chemdex, Inc - Form 483, 2023-02-27 |
June, 2023 | FDA 483 | University of Iowa Pharmaceuticals - Form 483, 2023-06-22 |
December, 2022 | FDA 483 | Nomax, INC - Form 483, 2022-12-02 |
April, 2023 | FDA 483 | Apollo Care, LLC - Form 483, 2023-04-05 |
September, 2023 | FDA 483 | Cosmetic Solutions, LLC - Form 483, 2023-09-21 |
December, 2023 | FDA 483 | Aura Cacia - Form 483, 2023-12-01 |
February, 2024 | FDA 483 | Centaur, Inc. - Form 483, 2024-02-01 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more